Polaryx Therapeutics, Inc Common Stock

Polaryx Therapeutics, Inc Common Stock

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$0
EBITDA
-3,328
-1,380
-2,544
-1,495
EBIT
-3,328
-1,380
-1,958
-911
Net Income
-3,328
-1,380
-2,544
-1,495
Net Change In Cash
0
0
0
0
Free Cash Flow
-3,102
-1,369
-2,063
-1,490
Cash
8,440
11,542
3,080
5,143
Basic Shares
49,845
48,278
47,219
47,343

Annual Financials

Values in thousands2025-12-312024-12-312023-12-31
Revenue
$0
$0
$0
EBITDA
-8,985
-30,356
-3,779
EBIT
-7,821
-4,352
-3,781
Net Income
-8,985
-30,356
-3,779
Net Change In Cash
0
0
0
Free Cash Flow
-3,944
-2,573
-173
Cash
5,143
4,621
2
Basic Shares
47,343
189,372
189,372

Earnings Calls

QuarterEPS
2026-09-30
-$0.07
2026-06-30
-$0.03
2026-03-31
-$0.05
2025-12-31
-$0.16